BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29325677)

  • 1. Chronic obstructive pulmonary disease among lung cancer-free smokers: The importance of healthy controls.
    Karpman MD; Eldridge R; Follis JL; Etzel CJ; Shete S; El-Zein RA
    Respir Investig; 2018 Jan; 56(1):28-33. PubMed ID: 29325677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the cytokinesis-blocked micronucleus assay to detect gender differences and genetic instability in a lung cancer case-control study.
    McHugh MK; Lopez MS; Ho CH; Spitz MR; Etzel CJ; El-Zein RA
    Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):135-45. PubMed ID: 23195992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in chronic obstructive pulmonary disease phenotypes between non-smokers and smokers.
    Ji W; Lim MN; Bak SH; Hong SH; Han SS; Lee SJ; Kim WJ; Hong Y
    Clin Respir J; 2018 Feb; 12(2):666-673. PubMed ID: 27805311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The occurrence of chronic obstructive pulmonary disease (COPD) in cigarette smoking families.
    Kałucka S
    Przegl Lek; 2006; 63(10):848-57. PubMed ID: 17288170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The added value of hybrid ventilation/perfusion SPECT/CT in patients with stable COPD or apparently healthy smokers. Cancer-suspected CT findings in the lungs are common when hybrid imaging is used.
    Jögi J; Markstad H; Tufvesson E; Bjermer L; Bajc M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():25-30. PubMed ID: 25565797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voluntary lung function screening to reveal new COPD cases in southern Italy.
    Capozzolo A; Castellana G; Dragonieri S; Carratù P; Liotino V; Vulpi MR; Marra L; Resta E; Intiglietta P; Resta O
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2035-2042. PubMed ID: 28744118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk.
    El-Zein RA; Schabath MB; Etzel CJ; Lopez MS; Franklin JD; Spitz MR
    Cancer Res; 2006 Jun; 66(12):6449-56. PubMed ID: 16778224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of frequency of undiagnosed chronic obstructive pulmonary disease in current or former tobacco smokers having ischaemic heart disease.
    Mahmud T; Bokhari SN; Aasim M
    Indian J Chest Dis Allied Sci; 2012; 54(2):111-6. PubMed ID: 22973780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender and chronic obstructive pulmonary disease in high-risk smokers.
    de Torres JP; Campo A; Casanova C; Aguirre-Jaime A; Zulueta J
    Respiration; 2006; 73(3):306-10. PubMed ID: 16330871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between chronic obstructive pulmonary disease and lung cancer: a case-control study in Southern Chinese and a meta-analysis.
    Wang H; Yang L; Zou L; Huang D; Guo Y; Pan M; Tan Y; Zhong H; Ji W; Ran P; Zhong N; Lu J
    PLoS One; 2012; 7(9):e46144. PubMed ID: 23029414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An association between chronic obstructive pulmonary disease and abdominal aortic aneurysm beyond smoking: results from a case-control study.
    Meijer CA; Kokje VB; van Tongeren RB; Hamming JF; van Bockel JH; Möller GM; Lindeman JH
    Eur J Vasc Endovasc Surg; 2012 Aug; 44(2):153-7. PubMed ID: 22705161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-
    Banerjee S; Bhattacharyya P; Mitra S; Kundu S; Panda S; Chatterjee IB
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1847-1856. PubMed ID: 28684907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic obstructive pulmonary disease and risk of lung cancer: the importance of smoking and timing of diagnosis.
    Powell HA; Iyen-Omofoman B; Baldwin DR; Hubbard RB; Tata LJ
    J Thorac Oncol; 2013 Jan; 8(1):6-11. PubMed ID: 23196277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and diagnosis of chronic obstructive pulmonary disease among smokers at risk. A comparative study of case-finding vs. screening strategies.
    Sansores RH; Ramírez-Venegas A; Hernández-Zenteno R; Mayar-Maya ME; Pérez-Bautista OG; Velázquez Uncal M
    Respir Med; 2013 Apr; 107(4):580-6. PubMed ID: 23313037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of chronic obstructive pulmonary disease in asymptomatic smokers.
    Sansores RH; Velázquez-Uncal M; Pérez-Bautista O; Villalba-Caloca J; Falfán-Valencia R; Ramírez-Venegas A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2357-63. PubMed ID: 26586941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin condition and its relationship to systemic inflammation in chronic obstructive pulmonary disease.
    Majewski S; Pietrzak A; Tworek D; Szewczyk K; Kumor-Kisielewska A; Kurmanowska Z; Górski P; Zalewska-Janowska A; Piotrowski WJ
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2407-2415. PubMed ID: 28860735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of COPD patients in GOLD 0 population: an observational non-interventional cohort study - MARKO study.
    Vrbica Ž; Labor M; Gudelj I; Labor S; Jurić I; Plavec D;
    BMC Pulm Med; 2017 Feb; 17(1):36. PubMed ID: 28187733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of smoking-cessation pharmacotherapy among chronic obstructive pulmonary disease (COPD) and lung cancer patients.
    Vaidya V; Hufstader-Gabriel M; Gangan N; Shah S; Bechtol R
    Curr Med Res Opin; 2014 Jun; 30(6):1043-50. PubMed ID: 24432816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of passive smoking in home environment.
    Kałucka S
    Przegl Lek; 2007; 64(10):632-41. PubMed ID: 18409274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel.
    Stav D; Raz M
    Isr Med Assoc J; 2007 Nov; 9(11):800-2. PubMed ID: 18085037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.